UArizona Health Sciences Excels in Latest Blue Ridge Rankings on NIH Funding Feb. 17, 2021 Increases in total National Institutes of Health funding have led to higher rankings for several colleges and departments. Read more Image
How the Art of Improv Can Teach Humanistic Care Feb. 17, 2021 Students at the College of Medicine – Phoenix learn how listening and reacting to a partner on stage applies to the doctor-patient relationship. Read more Image
University of Arizona Studying COVID-19 Vaccine Efficacy Feb. 17, 2021 The University of Arizona has been studying COVID-19 since the pandemic began. Dr. Jeff Burgess, an Associate Dean for Research and Professor in the College of Public Health, has been leading a study that has followed more than 2,500 people throughout the pandemic. Dr. Burgess has been examining the risk of reinfection to those who are in high-risk environments like nurses and first responders. KGUN-TV (Tucson, AZ)
UArizona Researchers Release Report on the Declining Period of Crisis to One of Elevated Risk Feb. 17, 2021 With the fourth week in a row of declining COVID-19 cases in Pima County, Arizona has evolved from a state of "crisis" to one of "elevated risk," according to Joe Gerald, an associate professor in the University of Arizona's Mel and Enid Zuckerman College of Public Health who creates weekly coronavirus epidemiology reports based on Arizona Department of Health Services data. KVOA-TV (Tucson, AZ)
Don’t Look for the “Quick Fix” to Regain Your Sense of Smell After Having COVID-19 Feb. 17, 2021 There are different stages to loss of smell, but what is most commonly reported as a COVID-19 symptom is a complete loss of smell or anosmia. Dr. Eugene Chang, a surgeon-scientist and the vice-chair of the UArizona otolaryngology department at the College of Medicine - Tucson, explains why the loss of smell is one of the first symptoms that can present with COVID- 19 infection. KGUN-TV (Tucson, AZ)
Doctor Addresses Concerns Over Lower Vaccine Efficacy Feb. 17, 2021 Now that multiple COVID-19 vaccinations are on, or are soon to be on the market, there's a percentage of efficacy attached to each of them. Pfizer and Moderna are promising about 95% protection after two doses. And Johnson and Johnson is promising 66% after one dose. But what does that actually mean? "It's not like me, myself, now has 66% immunity. It's more of a population measure," says Dr. Deepta Bhattacharya, University of Arizona College of Medicine. It comes down to clinical trials. KGUN-TV (Tucson, AZ)
Dr. Cheryl Lacasse Recognized as Distinguished Educator in Gerontological Nursing Feb. 16, 2021 Read more Image
Statewide Antibody Testing Initiative Reaches Milestone, Expects Vaccine-Related Increase in Registrations Feb. 16, 2021 The antibody test developed by the UArizonaHealth Sciences research team can be used to confirm a positive antibody response after receiving a COVID-19 vaccine. Read more Image
Workplace Chemical Exposure Study Leads to Small Business COVID-19 Awareness Campaign Feb. 16, 2021 A public health research team is providing guidance to beauty, auto shop owners in Spanish-speaking areas to reduce COVID-19 infection risks. Read more Image